Brean Downgrades United Therapeutics (UTHR) to Hold, Says Price Target Acheived
Tweet Send to a Friend
Brean Capital downgraded United Therapeutics Corp. (NASDAQ: UTHR) from Buy to Hold.
"We are downgrading United to Hold from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
"We are downgrading United to Hold from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
